Medicare Enrolled

Dr. Peter Futrell, M.D.

Neurology · Cumming, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1100 NORTHSIDE FORSYTH DR STE 440, Cumming, GA 30041
7702034881
In practice since 2005 (20 years)
NPI: 1912990391 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Futrell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Futrell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Futrell

Dr. Peter Futrell is a neurology specialist in Cumming, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Futrell performed 2,229 Medicare services across 1,203 unique beneficiaries.

Between the years covered by Open Payments, Dr. Futrell received a total of $33,014 from 97 pharmaceutical and/or device companies across 1889 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Futrell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in GA $33,014 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,229
Medicare services
Top 18% in GA for neurology
1,203
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
684 $65 $249
Continuous intraoperative neurophysiology monitoring, remote
Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments.
485 $24 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
343 $96 $362
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
132 $120 $497
Placement of skin electrodes and measurement of stimulated sites on arms and legs
This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs.
95 $33 $150
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
91 $62 $235
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
68 $83 $339
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
51 $325 $650
Electromyography of 2 extremities
A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function.
49 $60 $300
Central motor stimulation test of arms and legs
This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs.
43 $87 $321
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
34 $102 $165
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
30 $218 $285
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
25 $32 $180
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
25 $136 $533
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
22 $297 $537
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $100 $394
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
19 $94 $355
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
13 $43 $143
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$33,014
Total received (2018-2024)
Avg $4,716/year across 7 years
Top 11% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
1,889
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,954 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,541
2023
$3,963
2022
$4,364
2021
$6,874
2020
$5,056
2019
$4,453
2018
$3,763

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$538
MDD US Operations, LLC
$485
PFIZER INC.
$439
CATALYST PHARMACEUTICALS, INC.
$287
ACADIA Pharmaceuticals Inc
$227
Lundbeck LLC
$222
UCB, Inc.
$216
Eisai Inc.
$202
Otsuka America Pharmaceutical, Inc.
$197
Biogen, Inc.
$185
Neurocrine Biosciences, Inc.
$177
Lilly USA, LLC
$165
Alexion Pharmaceuticals, Inc.
$159
Teva Pharmaceuticals USA, Inc.
$141
Sumitomo Pharma America, Inc.
$131
Novartis Pharmaceuticals Corporation
$112
ARGENX US, INC.
$105
Ipsen Biopharmaceuticals, Inc
$85
SCILEX PHARMACEUTICALS INC.
$62
Neurelis, Inc.
$55
Cycle Pharmaceuticals Inc
$55
JAZZ PHARMACEUTICALS INC.
$52
Azurity Pharmaceuticals, Inc.
$41
Aucta Pharmaceuticals, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$28
Genentech USA, Inc.
$28
Kedrion Biopharma, Inc.
$25
Celgene Corporation
$24
Kyowa Kirin, Inc.
$24
AstraZeneca Pharmaceuticals LP
$23
Grifols USA, LLC
$22
Top 3 companies account for 32.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,982
Biogen, Inc.
$1,831
ABBVIE INC.
$1,773
Novartis Pharmaceuticals Corporation
$1,199
AbbVie Inc.
$1,186
ACADIA Pharmaceuticals Inc
$1,156
EMD Serono, Inc.
$1,125
Sunovion Pharmaceuticals Inc.
$1,095
Alexion Pharmaceuticals, Inc.
$1,091
Amgen Inc.
$1,057
Lundbeck LLC
$1,046
PFIZER INC.
$959
Biohaven Pharmaceuticals, Inc.
$911
Teva Pharmaceuticals USA, Inc.
$909
Eisai Inc.
$874
Neurocrine Biosciences, Inc.
$862
Avanir Pharmaceuticals, Inc.
$852
Lilly USA, LLC
$837
Supernus Pharmaceuticals, Inc.
$776
MDD US Operations, LLC
$563
GENZYME CORPORATION
$554
Otsuka America Pharmaceutical, Inc.
$550
Allergan, Inc.
$547
Biohaven Pharmaceutical Holding Company Ltd.
$427
JAZZ PHARMACEUTICALS INC.
$418
US WorldMeds, LLC
$386
Adamas Pharmaceuticals, Inc.
$381
Kyowa Kirin, Inc.
$374
EISAI INC.
$373
CSL Behring
$341
Sumitomo Pharma America, Inc.
$321
Bausch Health US, LLC
$306
Amneal Pharmaceuticals LLC
$303
Allergan Inc.
$300
CATALYST PHARMACEUTICALS, INC.
$287
IMPEL PHARMACEUTICALS INC.
$255
ARGENX US, INC.
$244
Ipsen Biopharmaceuticals, Inc
$234
AbbVie, Inc.
$233
Celgene Corporation
$225
BANNER LIFE SCIENCES, LLC
$207
AstraZeneca Pharmaceuticals LP
$204
Mallinckrodt Hospital Products Inc.
$194
Neurelis, Inc.
$152
Grifols USA, LLC
$151
Janssen Pharmaceuticals, Inc
$149
Harmony Biosciences LLC
$146
Currax Pharmaceuticals LLC
$137
Acorda Therapeutics, Inc
$128
Egalet US Inc
$115
Avion Pharmaceuticals
$108
GE HEALTHCARE
$105
Upsher-Smith Laboratories LLC
$103
SK Life Science, Inc.
$96
Catalyst Pharmaceuticals, Inc.
$93
Aprecia Pharmaceuticals, LLC
$82
Boston Scientific Corporation
$78
Promius Pharma LLC
$78
Mallinckrodt LLC
$77
Azurity Pharmaceuticals, Inc.
$76
Jazz Pharmaceuticals Inc.
$76
Takeda Pharmaceuticals U.S.A., Inc.
$74
UPSHER-SMITH LABORATORIES LLC
$74
Vertical Pharmaceuticals, LLC
$68
Corium, LLC
$63
SCILEX PHARMACEUTICALS INC.
$62
Genentech USA, Inc.
$62
Impax Laboratories, Inc.
$61
Mallinckrodt Enterprises LLC
$59
ARBOR PHARMACEUTICALS, INC.
$57
Cycle Pharmaceuticals Inc
$55
HARMONY BIOSCIENCES LLC
$52
Axsome Therapeutics, Inc.
$51
GE Healthcare
$44
E.R. Squibb & Sons, L.L.C.
$39
Medtronic USA, Inc.
$39
Greenwich Biosciences, Inc.
$38
SANOFI-AVENTIS U.S. LLC
$36
LivaNova USA, Inc.
$36
Merz North America, Inc.
$34
Aucta Pharmaceuticals, Inc.
$31
TerSera Therapeutics LLC
$27
MITSUBISHI TANABE PHARMA AMERICA, INC.
$25
Kedrion Biopharma, Inc.
$25
Horizon Therapeutics plc
$23
Octapharma USA, Inc.
$20
Mylan Pharmaceuticals Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$18
Zyla Life Sciences, Inc.
$17
Assertio Therapeutics, Inc.
$17
Abbott Laboratories
$17
Collegium Pharmaceutical, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
ASSERTIO THERAPEUTICS, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
Merck Sharp & Dohme Corporation
$11
OWP Pharmaceuticals, Inc.
$11
Top 3 companies account for 16.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Albuked · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · CAMBIA · CHANTIX · COMIRNATY · COPAXONE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · FYCOMPA · Fycompa · GAMMAGARD · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · General - Pain Management · Glatiramer Acetate · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PLEGRIDY · POMPE - DISEASE · PRIALT · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · Soliris · Spritam · Subvenite · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · Utibron · VALTOCO · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · WaveWriter Alpha Prime 16 · XEOMIN · XYREM · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Cumming?
Compare neurologists in the Cumming area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
88
Per 100K population
33.8
County median income
$138,000
Nearest hospital
NORTHSIDE HOSPITAL FORSYTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Futrell is a clinical cardiology specialist, with above-average Medicare volume (top 18% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Futrell experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Futrell performed 684 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Futrell receive payments from pharmaceutical companies?
Yes. Dr. Futrell received a total of $33,014 from 97 companies across 1,889 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Futrell's costs compare to other neurologists in Cumming?
Dr. Futrell's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Futrell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →